A. Emery, Population frequencies of inherited neuromuscular diseases???A world survey, Neuromuscular Disorders, vol.1, issue.1, pp.19-29, 1991.
DOI : 10.1016/0960-8966(91)90039-U

R. Baxter, B. Othmane, K. Rochelle, J. Stajich, J. Hulette et al., Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21, Nature Genetics, vol.30, issue.1, pp.21-22, 2002.
DOI : 10.1038/ng796

A. Cuesta, L. Pedrola, T. Sevilla, J. Garcia-planells, M. Chumillas et al., The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease, Nature Genetics, vol.30, issue.1, pp.22-25, 2002.
DOI : 10.1038/ng798

J. Senderek, C. Bergmann, V. Ramaekers, E. Nelis, G. Bernert et al., Mutations in the ganglioside-induced differentiation-associated protein-1 (GDAP1) gene in intermediate type autosomal recessive Charcot-Marie-Tooth neuropathy, Brain, vol.126, issue.3, pp.642-649, 2003.
DOI : 10.1093/brain/awg068

J. Cassereau, A. Chevrollier, N. Gueguen, M. Malinge, F. Letournel et al., Mitochondrial complex I deficiency in GDAP1-related autosomal dominant Charcot-Marie-Tooth disease (CMT2K), neurogenetics, vol.292, issue.2, pp.145-150, 2009.
DOI : 10.1007/s10048-008-0166-9

K. Chung, S. Kim, I. Sunwoo, S. Cho, S. Hwang et al., A novel GDAP1 Q218E mutation in autosomal dominant Charcot-Marie-Tooth disease, Journal of Human Genetics, vol.14, issue.4, pp.360-364, 2008.
DOI : 10.1007/s10038-008-0249-3

R. Claramunt, L. Pedrola, T. Sevilla, A. Lopez-de-munain, J. Berciano et al., Genetics of Charcot-Marie-Tooth disease type 4A: mutations, inheritance, phenotypic variability, and founder effect, Journal of Medical Genetics, vol.42, issue.4, pp.358-365, 2005.
DOI : 10.1136/jmg.2004.022178

B. Othmane, K. Hentati, F. Lennon, F. , B. Hamida et al., Linkage of a locus (CMT4A) for autosomal recessive Charcot-Marie-Tooth disease to chromosome 8q, Human Molecular Genetics, vol.2, issue.10, pp.1625-1628, 1993.
DOI : 10.1093/hmg/2.10.1625

H. Liu, T. Nakagawa, T. Kanematsu, T. Uchida, and S. Tsuji, Isolation of 10 Differentially Expressed cDNAs in Differentiated Neuro2a Cells Induced Through Controlled Expression of the GD3 Synthase Gene, Journal of Neurochemistry, vol.66, issue.5, pp.1781-1790, 1999.
DOI : 10.1046/j.1471-4159.1999.0721781.x

A. Marco, A. Cuesta, L. Pedrola, F. Palau, and I. Marin, Evolutionary and Structural Analyses of GDAP1, Involved in Charcot-Marie-Tooth Disease, Characterize a Novel Class of Glutathione Transferase-Related Genes, Molecular Biology and Evolution, vol.21, issue.1, pp.176-187, 2004.
DOI : 10.1093/molbev/msh013

A. Shield, T. Murray, and P. Board, Functional characterisation of ganglioside-induced differentiation-associated protein 1 as a glutathione transferase, Biochemical and Biophysical Research Communications, vol.347, issue.4, pp.859-866, 2006.
DOI : 10.1016/j.bbrc.2006.06.189

L. Pedrola, A. Espert, X. Wu, R. Claramunt, and M. Shy, GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria, Human Molecular Genetics, vol.14, issue.8, pp.1087-1094, 2005.
DOI : 10.1093/hmg/ddi121

K. Wagner, M. Ruegg, A. Niemann, and U. Suter, Targeting and Function of the Mitochondrial Fission Factor GDAP1 Are Dependent on Its Tail-Anchor, PLoS ONE, vol.15, issue.4, p.5160, 2009.
DOI : 10.1371/journal.pone.0005160.s006

A. Niemann, M. Ruegg, L. Padula, V. Schenone, A. Suter et al., Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network, The Journal of Cell Biology, vol.41, issue.7, pp.1067-1078, 2005.
DOI : 10.1038/ng1341

L. Pedrola, A. Espert, T. Valdes-sanchez, M. Sanchez-piris, E. Sirkowski et al., Cell expression of GDAP1 in the nervous system and pathogenesis of Charcot-Marie-Tooth type 4A disease, Journal of Cellular and Molecular Medicine, vol.59, issue.2, pp.679-689, 2008.
DOI : 10.1016/S0960-8966(03)00093-2

J. Cassereau, A. Chevrollier, N. Gueguen, V. Desquiret, C. Verny et al., Mitochondrial dysfunction and pathophysiology of Charcot???Marie???Tooth disease involving GDAP1 mutations, Experimental Neurology, vol.227, issue.1, pp.31-41, 2011.
DOI : 10.1016/j.expneurol.2010.09.006

I. Moroni, M. Morbin, M. Milani, C. Ciano, M. Bugiani et al., Novel mutations in the GDAP1 gene in patients affected with early-onset axonal Charcot-Marie-Tooth type 4A, Neuromuscular Disorders, vol.19, issue.7, pp.476-480, 2009.
DOI : 10.1016/j.nmd.2009.04.014

H. Azzedine, M. Ruberg, D. Ente, C. Gilardeau, S. Perie et al., Variability of disease progression in a family with autosomal recessive CMT associated with a S194X and new R310Q mutation in the GDAP1 gene, Neuromuscular Disorders, vol.13, issue.4, pp.341-346, 2003.
DOI : 10.1016/S0960-8966(02)00281-X

I. Fokkema, P. Taschner, G. Schaafsma, J. Celli, and J. Laros, den Dunnen JT: LOVD v.2.0: the next generation in gene variant databases. Human mutation, pp.557-563, 2011.

M. Wildeman, E. Van-ophuizen, J. Den-dunnen, and P. Taschner, Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker. Human mutation, pp.6-13, 2008.

J. Den-dunnen and S. Antonarakis, Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion, Human Mutation, vol.10, issue.1, pp.7-12, 2000.
DOI : 10.1002/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N

J. Den-dunnen and M. Paalman, Standardizing mutation nomenclature: why bother? Hum Mutat, pp.181-182, 2003.

C. Crimella, A. Tonelli, G. Airoldi, C. Baschirotto, D. Angelo et al., The GST domain of GDAP1 is a frequent target of mutations in the dominant form of axonal Charcot Marie Tooth type 2K, Journal of Medical Genetics, vol.47, issue.10, pp.712-716, 2010.
DOI : 10.1136/jmg.2010.077909

URL : https://hal.archives-ouvertes.fr/hal-00557397

O. Dubourg, Charcot???Marie???Tooth diseases, Revue neurologique, vol.160, pp.1221-1229, 2004.
DOI : 10.1017/CBO9781139087711.012

N. Birouk, R. Gouider, L. Guern, E. Gugenheim, M. Tardieu et al., Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases, Brain, vol.120, issue.5, pp.120813-823, 1997.
DOI : 10.1093/brain/120.5.813

N. Hattori, M. Yamamoto, T. Yoshihara, H. Koike, M. Nakagawa et al., Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients, Brain, vol.126, issue.1, pp.134-151, 2003.
DOI : 10.1093/brain/awg012

R. Lewis, A. Sumner, and M. Shy, Electrophysiological features of inherited demyelinating neuropathies: A reappraisal in the era of molecular diagnosis, Muscle & Nerve, vol.43, issue.10, pp.1472-1487, 2000.
DOI : 10.1002/1097-4598(200010)23:10<1472::AID-MUS3>3.0.CO;2-#

O. Dubourg, H. Azzedine, C. Verny, G. Durosier, N. Birouk et al., Autosomal-recessive forms of demyelinating Charcot-Marie-Tooth disease, NeuroMolecular Medicine, vol.8, issue.1-2, pp.75-86, 2006.
DOI : 10.1385/NMM:8:1-2:75

J. Cassereau, C. Casasnovas, N. Gueguen, M. Malinge, V. Guillet et al., Simultaneous MFN2 and GDAP1 mutations cause major mitochondrial defects in a patient with CMT, Neurology, vol.76, issue.17, pp.1524-1526, 2011.
DOI : 10.1212/WNL.0b013e318217e77d

M. Ferre, P. Amati-bonneau, Y. Tourmen, Y. Malthiery, and P. Reynier, an online database for OPA1 mutations, Human mutation, vol.25, pp.1423-428, 2005.

S. Zuchner, I. Mersiyanova, M. Muglia, N. Bissar-tadmouri, J. Rochelle et al., Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A, Nature Genetics, vol.8, issue.5, pp.449-451, 2004.
DOI : 10.1083/jcb.200209124

H. Waterham, J. Koster, C. Van-roermund, P. Mooyer, R. Wanders et al., A Lethal Defect of Mitochondrial and Peroxisomal Fission, New England Journal of Medicine, vol.356, issue.17, pp.1736-1741, 2007.
DOI : 10.1056/NEJMoa064436